A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors
J5M-OX-JOXA
Phase 1 other active
Quick answer
A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors for Metastatic Solid Tumor Advanced Solid Tumor Non-small Cell Lung Cancer SMARCA4-Deficient Tumor is a Phase 1 program (other) at Eli Lilly Co. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Eli Lilly Co.
- Indication
- Metastatic Solid Tumor Advanced Solid Tumor Non-small Cell Lung Cancer SMARCA4-Deficient Tumor
- Phase
- Phase 1
- Modality
- other
- Status
- active